SynBioBeta Speaker

Christopher Pirie

Decycle Bio

CEO

Dr. Christopher Pirie is a biotechnology executive and serial entrepreneur. He is co-founder and CEO of Decycle Bio where they're commercializing de-novo-designed, cell-free reaction cascades for platform chemicals. He previously served as co-founder and Chief Operating Officer of HDT Bio, an RNA vaccines company, where he helped to secure and service >$100M in federal grants/contracts, commercial partnership agreements, and equity financing. Before that he was co-founder and CEO of Virvio, a biopharmaceutical company spun out of the Institute for Protein Design and focused on designer proteins for respiratory diseases like influenza. He also co-founded Manus Bio where he built and ran the enzyme engineering team while leading intellectual property development. Dr. Pirie coaches entrepreneurship workshops around the world with MIT Sloan Business School and has mentored early-stage startups through the Buerk Center for Entrepreneurship at UW. When he’s not working, he is a father of two, avid soccer player, and occasional sailor.

Sessions Featuring

Christopher

This Year

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Previous Speakers Include